A situation was identified where the cobas Liat analyzer was manufactured and distributed with 3 assay scripts pre-loaded on the instrument. One of the assay script (cobas Liat Strep A) is not yet licenced in Canada. However, there is no user-impact since the assay is not available in Canada and is not functional on the analyzer leading to no consequence on result reliability.